Annual report pursuant to Section 13 and 15(d)

Consolidated Financial Statement Detail (Tables)

v2.4.0.8
Consolidated Financial Statement Detail (Tables)
12 Months Ended
Dec. 31, 2013
Consolidated Financial Statement Detail [Abstract]  
Receivables
Receivables consisted of the following at December 31, 2013 and 2012 (in thousands):

   
December 31,
 
   
2013
   
2012
 
Trade receivables, net
  $ 3,731     $ 7,477  
Other receivables
    50       772  
Total
  $ 3,781     $ 8,249  

Property and equipment
Property and equipment consisted of the following at December 31, 2013 and 2012 (in thousands):

   
December 31,
 
   
2013
   
2012
 
Equipment and furniture
  $ 28,365     $ 25,734  
Buildings, leasehold and building improvements
    9,316       21,656  
Construction-in-progress
    225       1,832  
Land
    310       310  
      38,216       49,532  
Less:  Accumulated depreciation and amortization
    (31,760 )     (41,389 )
Property and equipment, net
  $ 6,456     $ 8,143  

Accrued liabilities
Accrued liabilities consisted of the following at December 31, 2013 and 2012 (in thousands):

   
December 31,
 
   
2013
   
2012
 
Accrued management incentive compensation
  $ 4,386     $ 3,978  
Accrued payroll and other benefits
    3,009       2,461  
Accrued clinical trial costs
    878       4,702  
Other
    1,661       1,904  
Total
  $ 9,934     $ 13,045